As GLUT1 has been reported to be ubiquitously distributed in all tissues [10] and GLUT3 is predominantly expressed in neuronal tissues, placenta, testis, myocardium, and platelets in humans [10, 61–63], GLUT3 appears to be a more promising therapeutic target for the specific treatment of melanoma. Here, SLC2A1 is linked to melanoma.